A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Current anticancer treatments essentially target the primary tumour cells that proliferate quickly, but do not effectively ...

A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer ...

I want to know if the risk of cancer increases with age. Goriola (by SMS) Our physical structure changes multiple times throughout the process of aging. The significant health change that occurs in ...

Blocking the carrier could then starve these cancer cells of the energy they need to ... "This creates new opportunities for structure-based drug design in order to develop better, more targeted ...

These cells have the potential to be highly effective cancer eradicators that can perform ... encoded by Zeb2 works by changing the physical structure of the genome, known as the epigenome ...

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in ... It is from these cells, which express a gene called Krt5 that helps to build the structure of ...

“I thought it had a structure similar to some of the drugs ... 2021 that showed pyronaridine inhibited topoisomerase II in cancer cells. “Topoisomerase II is essential for cell survival ...